Question 1

Is Bevacizumab currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Bevacizumab has 7 active shortage notices across 3 countries (Italy, European Union, Belgium). Status is refreshed daily from official regulatory sources.

Question 2

Why is Bevacizumab in shortage?

Accepted Answer

Regulators attribute the current Bevacizumab shortages to unexpected increases in demand, manufacturing problems, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Bevacizumab shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 1 Apr 2026 to 1 Apr 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Bevacizumab shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Italy	critical	4	1 Dec 2025	1 Apr 2026	AIFA
European Union

Bevacizumab shortage status

Where Bevacizumab is in shortage

Why Bevacizumab is in shortage

Recent shortage history

Frequently asked questions

Related medicines

Get alerted when Bevacizumab status changes